INOVIO to Present at Upcoming Scientific Conferences

Rhea-AI Summary

INOVIO (NASDAQ:INO), a biotechnology company developing DNA medicines, announced its participation in four upcoming scientific conferences. These include:

1. AACR Special Conference in Boston, MA (Oct 19, 2024): Dr. Matthew Morrow will present a poster on INO-3107's impact on reducing surgical interventions for Recurrent Respiratory Papillomatosis (RRP).

2. ISV Congress 2024 in Seoul, Korea (Oct 22, 2024): Dr. Michael Sumner will give an oral presentation and poster on the clinical assessment of INO-3107 in adult RRP patients.

3. Fall Voice in Phoenix, AZ (Oct 25-26, 2024): Dr. Jeffrey Skolnik will present a poster on the clinical assessment of INO-3107 in adult RRP patients.

4. World Vaccine Congress Europe in Barcelona, Spain (Oct 28, 2024): Dr. Dave Liebowitz will give a presentation and participate in a panel discussion on platform technologies.

Abstracts from these conferences will be available on INOVIO's website after each presentation.

News Market Reaction – INO

-2.77%

1 alert

-2.77% News Effect

On the day this news was published, INO declined 2.77%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

PLYMOUTH MEETING, Pa., Oct. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that it will present at the following scientific conferences:

AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy
Poster by Dr. Matthew Morrow, VP of Translational Sciences at INOVIO
Abstract Title: Reduction in Surgical Interventions for the Treatment of Recurrent Respiratory Papillomatosis by INO-3107 is Associated with Enriched Macrophage, Dendritic cell and T cell Signatures in Patient Airways
Date and Time: October 19, 2024, 6:00 - 8:15pm ET
Location: Boston, MA

ISV Congress 2024
Oral presentation and poster by Dr. Michael Sumner, Chief Medical Officer at INOVIO
Abstract Title: Clinical Assessment of Adjuvant Immunotherapy, INO-3107, in Adult Patients with Recurrent Respiratory Papillomatosis (RRP)
Date and Time: October 22, 2024, 4:20pm KST
Location: Seoul, Korea

Fall Voice
Poster by Dr. Jeffrey Skolnik, SVP of Clinical Development at INOVIO
Abstract Title: Clinical Assessment of Adjuvant Immunotherapy, INO-3107, in Adult Patients with Recurrent Respiratory Papillomatosis (RRP)
Date and Time: October 25 – October 26, 2024
Location: Phoenix, AZ

World Vaccine Congress Europe
Presentation and panel discussion by Dr. Dave Liebowitz, SVP Early-Stage Clinical Development at INOVIO
Track: Pre-Congress Workshop on Platform Technologies
Date and Time: October 28, 2024, 10:00am CET
Location: Barcelona, Spain

Abstracts from these conferences will be made available on INOVIO's website following each presentation.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-present-at-upcoming-scientific-conferences-302263723.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

What conferences will INOVIO (INO) present at in October 2024?

INOVIO will present at four conferences in October 2024: AACR Special Conference in Boston, ISV Congress in Seoul, Fall Voice in Phoenix, and World Vaccine Congress Europe in Barcelona.

What is the focus of INOVIO's (INO) presentations at these conferences?

INOVIO's presentations primarily focus on INO-3107, their DNA medicine for treating Recurrent Respiratory Papillomatosis (RRP), including its clinical assessment and impact on reducing surgical interventions.

Who will be presenting on behalf of INOVIO (INO) at these conferences?

Presenters include Dr. Matthew Morrow, Dr. Michael Sumner, Dr. Jeffrey Skolnik, and Dr. Dave Liebowitz, all holding senior positions at INOVIO.

When and where will INOVIO (INO) present at the ISV Congress 2024?

INOVIO will present at the ISV Congress 2024 on October 22, 2024, at 4:20pm KST in Seoul, Korea.

What is the topic of INOVIO's (INO) presentation at the World Vaccine Congress Europe?

At the World Vaccine Congress Europe, INOVIO will participate in a pre-congress workshop on platform technologies, with Dr. Dave Liebowitz giving a presentation and joining a panel discussion.